| scholarly article | Q13442814 |
| P2093 | author name string | Haixia Liu | |
| Peter A Simmons | |||
| Cindy Carlisle-Wilcox | |||
| Joseph G Vehige | |||
| P2860 | cites work | Comparison of in vivo efficacy of different ocular lubricants in dry eye animal models. | Q50427118 |
| Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena). | Q50558766 | ||
| Quality of reporting of noninferiority and equivalence randomized trials. | Q53000120 | ||
| Unpreserved carboxymethylcellulose artificial tears evaluated in patients with keratoconjunctivitis sicca | Q67574582 | ||
| Psychophysics of reading. VIII. The Minnesota Low-Vision Reading Test | Q69449534 | ||
| Reliability and validity of the Ocular Surface Disease Index | Q73801624 | ||
| Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing | Q80050222 | ||
| Clinical performance of a mid-viscosity artificial tear for dry eye treatment | Q80110356 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347909 | ||
| Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease | Q82285281 | ||
| Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease | Q83353719 | ||
| Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease | Q83829771 | ||
| Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy | Q85096789 | ||
| Spectral-domain optical coherence tomography study on dynamic changes of human tears after instillation of artificial tears | Q88198371 | ||
| Effect of carmellose-based artificial tears on the ocular surface in eyes after laser in situ keratomileusis. | Q30670740 | ||
| Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. | Q30813799 | ||
| A comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patients | Q31072203 | ||
| Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation. | Q33196311 | ||
| Effect of artificial tears on visual acuity | Q33227891 | ||
| A novel technique of contrast-enhanced optical coherence tomography imaging in evaluation of clearance of lipids in human tears. | Q34450082 | ||
| Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome | Q35307717 | ||
| Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye | Q35589451 | ||
| Impact of dry eye syndrome on vision-related quality of life | Q35741609 | ||
| Dysfunctional tear syndrome: a Delphi approach to treatment recommendations | Q36653052 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| T helper cytokines in dry eye disease | Q37374838 | ||
| Minimal clinically important difference for the ocular surface disease index | Q37672025 | ||
| Osmolality and tear film dynamics. | Q37948822 | ||
| Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting | Q38151227 | ||
| In vitro efficacy of ocular surface lubricants against dehydration | Q39125023 | ||
| Evaluation of the effects on conjunctival tissues of Optive eyedrops over one month usage | Q39289594 | ||
| A randomised, crossover, multicentre study to compare the performance of 0.1% (w/v) sodium hyaluronate with 1.4% (w/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome | Q39403809 | ||
| Precorneal residence time of artificial tears measured in dry eye subjects | Q40063368 | ||
| Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. | Q40412935 | ||
| Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye. | Q41813800 | ||
| Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. | Q43007758 | ||
| Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study. | Q43214337 | ||
| Comparison of fluorescein break-up time measurement reproducibility using standard fluorescein strips versus the Dry Eye Test (DET) method. | Q43783618 | ||
| A novel OCT technique to measure in vivo the corneal adhesiveness for sodium carboxymethylcellulose in humans and its validity in the diagnosis of dry eye. | Q45200076 | ||
| Carboxymethyl cellulose stimulates rabbit corneal epithelial wound healing | Q46502343 | ||
| Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells | Q46562064 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 665-675 | |
| P577 | publication date | 2015-04-15 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial | |
| P478 | volume | 9 |
| Q52643805 | Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease. |
| Q57378488 | Current and emerging therapy of dry eye disease. Part A: pharmacological modalities |
| Q36038395 | Dual-Polymer Drops, Contact Lens Comfort, and Lid Wiper Epitheliopathy |
| Q92236521 | Effect of Refresh Plus® preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects |
| Q36280601 | Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis |
| Q41817907 | Investigating the potential benefits of a new artificial tear formulation combining two polymers |
| Q38984001 | Investigational drugs in dry eye disease |
| Q53818675 | Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose. |
| Q47993522 | Ocular Effects of Sulfur Mustard and Therapeutic Approaches |
| Q42702543 | Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye. |
| Q24186110 | Over the counter (OTC) artificial tear drops for dry eye syndrome |
| Q92259326 | Polysaccharides in Ocular Drug Delivery |
| Q52661549 | Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products. |
| Q37569862 | The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals |
Search more.